A. Vidal

Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).

P. McNamara, S. Joseph, B. Laffitte, 2017, Journal of medicinal chemistry.

Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.

H. M. Petrassi, A. Patapoutian, Matt J. Petrus, 2014, Journal of medicinal chemistry.

Solid-phase synthesis of alpha,alpha-difluoro-beta-amino acids via the Reformatsky reaction.

R. Houghten, A. Nefzi, A. Vidal, 2001, The Journal of organic chemistry.

Solid-phase synthesis of 1,2,5-trisubstituted 4-imidazolidinones.

R. Houghten, A. Nefzi, M. Rinnová, 2002, Journal of combinatorial chemistry.

Synthesis of 19-[(2-azido-5-iodo)-benzoyloxy]-LTA4 and enzymatic conversion to the LTC4 analogue.

A. Sala, S. Zarini, T. Durand, 2000, Bioorganic & medicinal chemistry letters.

Solid-Phase Synthesis of α-Difluoro-β-amino Acids by a Reformatsky Reaction

R. Houghten, A. Vidal, and Adel Nefzi, 2001 .

Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.

H. M. Petrassi, Aaron Shipway, Jennifer L. Harris, 2008, Bioorganic & Medicinal Chemistry Letters.

Solid Phase Synthesis of 1,2,5-Substituted Derivatives of 4-Imidazolidinone

R. Houghten, A. Nefzi, M. Rinnová, 2001 .